APO RESEARCH · REPORT
Immunoprecipitation Testing
Immunoprecipitation (IP) is the small-scale affinity purification of antigens using a specific antibody that is immobilized to a solid support such as magnetic particles or agarose resin. Immunoprecipitation is one of the most widely used methods for isolation of proteins and other biomolecules from cell or tissue lysates for the purpose of subsequent detection by western blotting and other assay techniques.
Product & engineering
Understand the product.
Immunoprecipitation (IP) is the small-scale affinity purification of antigens using a specific antibody that is immobilized to a solid support such as magnetic particles or agarose resin. Immunoprecipitation is one of the most widely used methods for isolation of proteins and other biomolecules from cell or tissue lysates for the purpose of subsequent detection by western blotting and other assay techniques.
Selected research
Market Structure
Global Immunoprecipitation Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Immunoprecipitation (IP) is the small-scale affinity purification of antigens using a specific antibody that is immobilized to a solid support such as magnetic particles or agarose resin. Immunoprecipitation is one of the most widely used methods for isolation of proteins and other biomolecules from cell or tissue lysates for the purpose of subsequent detection by western blotting and other assay techniques.
The classification of Immunoprecipitation Testing includes Individual Protein Immunoprecipitation, Co-Immunoprecipitation (Co-IP), Chromatin Immunoprecipitation (ChIP), RNA Immunoprecipitation (RIP) and others. The proportion of Individual Protein Immunoprecipitation in 2019 is about34%, the proportion of Co-Immunoprecipitation (Co-IP) is 26% in 2019.
Immunoprecipitation Testing is widely used in Academic & Research Institutes, Pharmaceutical Companies and Contract Research Organizations. The most proportion of Immunoprecipitation Testing is Academic & Research Institutes, and the sales proportion in 2019 is 51%.
Read the full market overview
North America is the largest consumption place, with a consumption market share nearly 43% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is intense. Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GenScript, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report provides an overview of the global Immunoprecipitation Testing market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Immunoprecipitation Testing and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Immunoprecipitation Testing sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunoprecipitation Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
Immunoprecipitation Testing Segment by Company
Thermo Fischer Scientific
Merck
GenScript
Bio-Techne
BioLegend
Takara Bio
Abcam
Rockland Immunochemicals
Cell Signaling Technology
Geno Technology
Immunoprecipitation Testing Segment by Type
Individual Protein Immunoprecipitation
Co-Immunoprecipitation (Co-IP)
Chromatin Immunoprecipitation (ChIP)
RNA Immunoprecipitation (RIP)
Others
Immunoprecipitation Testing Segment by Application
Academic & Research Institutes
Pharmaceutical Companies
Contract Research Organizations
Immunoprecipitation Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunoprecipitation Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunoprecipitation Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunoprecipitation Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Immunoprecipitation Testing market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunoprecipitation Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunoprecipitation Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Immunoprecipitation Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Individual Protein Immunoprecipitation
- Co-Immunoprecipitation (Co-IP)
- Chromatin Immunoprecipitation (ChIP)
- RNA Immunoprecipitation (RIP)
- Others
Applications
- Academic & Research Institutes
- Pharmaceutical Companies
- Contract Research Organizations
Companies covered
- Thermo Fischer Scientific
- Merck
- GenScript
- Bio-Techne
- BioLegend
- Takara Bio
- Abcam
- Rockland Immunochemicals
- Cell Signaling Technology
- Geno Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Immunoprecipitation Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Immunoprecipitation Testing Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Immunoprecipitation Testing Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Immunoprecipitation Testing Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Immunoprecipitation Testing Market Dynamics
- 2.1 Immunoprecipitation Testing Industry Trends
- 2.2 Immunoprecipitation Testing Industry Drivers
- 2.3 Immunoprecipitation Testing Industry Opportunities and Challenges
- 2.4 Immunoprecipitation Testing Industry Restraints
3 Immunoprecipitation Testing Market by Manufacturers
- 3.1 Global Immunoprecipitation Testing Revenue by Manufacturers (2021-2026)
- 3.2 Global Immunoprecipitation Testing Sales by Manufacturers (2021-2026)
- 3.3 Global Immunoprecipitation Testing Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Immunoprecipitation Testing Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Immunoprecipitation Testing Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Immunoprecipitation Testing Manufacturers, Product Type & Application
- 3.7 Global Immunoprecipitation Testing Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Immunoprecipitation Testing Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Immunoprecipitation Testing Players Market Share by Revenue in 2025
- 3.8.3 2025 Immunoprecipitation Testing Tier 1, Tier 2, and Tier 3
4 Immunoprecipitation Testing Market by Type
- 4.1 Immunoprecipitation Testing Type Introduction
- 4.1.1 Individual Protein Immunoprecipitation
- 4.1.2 Co-Immunoprecipitation (Co-IP)
- 4.1.3 Chromatin Immunoprecipitation (ChIP)
- 4.1.4 RNA Immunoprecipitation (RIP)
- 4.1.5 Others
- 4.2 Global Immunoprecipitation Testing Sales by Type
- 4.2.1 Global Immunoprecipitation Testing Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Immunoprecipitation Testing Sales by Type (2021-2032)
- 4.2.3 Global Immunoprecipitation Testing Sales Market Share by Type (2021-2032)
- 4.3 Global Immunoprecipitation Testing Revenue by Type
- 4.3.1 Global Immunoprecipitation Testing Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Immunoprecipitation Testing Revenue by Type (2021-2032)
- 4.3.3 Global Immunoprecipitation Testing Revenue Market Share by Type (2021-2032)
5 Immunoprecipitation Testing Market by Application
- 5.1 Immunoprecipitation Testing Application Introduction
- 5.1.1 Academic & Research Institutes
- 5.1.2 Pharmaceutical Companies
- 5.1.3 Contract Research Organizations
- 5.2 Global Immunoprecipitation Testing Sales by Application
- 5.2.1 Global Immunoprecipitation Testing Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Immunoprecipitation Testing Sales by Application (2021-2032)
- 5.2.3 Global Immunoprecipitation Testing Sales Market Share by Application (2021-2032)
- 5.3 Global Immunoprecipitation Testing Revenue by Application
- 5.3.1 Global Immunoprecipitation Testing Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Immunoprecipitation Testing Revenue by Application (2021-2032)
- 5.3.3 Global Immunoprecipitation Testing Revenue Market Share by Application (2021-2032)
6 Global Immunoprecipitation Testing Sales by Region
- 6.1 Global Immunoprecipitation Testing Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Immunoprecipitation Testing Sales by Region (2021-2032)
- 6.2.1 Global Immunoprecipitation Testing Sales by Region (2021-2026)
- 6.2.2 Global Immunoprecipitation Testing Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Immunoprecipitation Testing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Immunoprecipitation Testing Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Immunoprecipitation Testing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Immunoprecipitation Testing Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Immunoprecipitation Testing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Immunoprecipitation Testing Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Immunoprecipitation Testing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Immunoprecipitation Testing Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Immunoprecipitation Testing Revenue by Region
- 7.1 Global Immunoprecipitation Testing Revenue by Region
- 7.1.1 Global Immunoprecipitation Testing Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Immunoprecipitation Testing Revenue by Region (2021-2026)
- 7.1.3 Global Immunoprecipitation Testing Revenue by Region (2027-2032)
- 7.1.4 Global Immunoprecipitation Testing Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Immunoprecipitation Testing Revenue (2021-2032)
- 7.2.2 North America Immunoprecipitation Testing Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Immunoprecipitation Testing Revenue (2021-2032)
- 7.3.2 Europe Immunoprecipitation Testing Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Immunoprecipitation Testing Revenue (2021-2032)
- 7.4.2 Asia-Pacific Immunoprecipitation Testing Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Immunoprecipitation Testing Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Immunoprecipitation Testing Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fischer Scientific
- 8.1.1 Thermo Fischer Scientific Company Information
- 8.1.2 Thermo Fischer Scientific Business Overview
- 8.1.3 Thermo Fischer Scientific Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fischer Scientific Immunoprecipitation Testing Product Portfolio
- 8.1.5 Thermo Fischer Scientific Recent Developments
- 8.2 Merck
- 8.2.1 Merck Company Information
- 8.2.2 Merck Business Overview
- 8.2.3 Merck Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck Immunoprecipitation Testing Product Portfolio
- 8.2.5 Merck Recent Developments
- 8.3 GenScript
- 8.3.1 GenScript Company Information
- 8.3.2 GenScript Business Overview
- 8.3.3 GenScript Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 GenScript Immunoprecipitation Testing Product Portfolio
- 8.3.5 GenScript Recent Developments
- 8.4 Bio-Techne
- 8.4.1 Bio-Techne Company Information
- 8.4.2 Bio-Techne Business Overview
- 8.4.3 Bio-Techne Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bio-Techne Immunoprecipitation Testing Product Portfolio
- 8.4.5 Bio-Techne Recent Developments
- 8.5 BioLegend
- 8.5.1 BioLegend Company Information
- 8.5.2 BioLegend Business Overview
- 8.5.3 BioLegend Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 BioLegend Immunoprecipitation Testing Product Portfolio
- 8.5.5 BioLegend Recent Developments
- 8.6 Takara Bio
- 8.6.1 Takara Bio Company Information
- 8.6.2 Takara Bio Business Overview
- 8.6.3 Takara Bio Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Takara Bio Immunoprecipitation Testing Product Portfolio
- 8.6.5 Takara Bio Recent Developments
- 8.7 Abcam
- 8.7.1 Abcam Company Information
- 8.7.2 Abcam Business Overview
- 8.7.3 Abcam Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Abcam Immunoprecipitation Testing Product Portfolio
- 8.7.5 Abcam Recent Developments
- 8.8 Rockland Immunochemicals
- 8.8.1 Rockland Immunochemicals Company Information
- 8.8.2 Rockland Immunochemicals Business Overview
- 8.8.3 Rockland Immunochemicals Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Rockland Immunochemicals Immunoprecipitation Testing Product Portfolio
- 8.8.5 Rockland Immunochemicals Recent Developments
- 8.9 Cell Signaling Technology
- 8.9.1 Cell Signaling Technology Company Information
- 8.9.2 Cell Signaling Technology Business Overview
- 8.9.3 Cell Signaling Technology Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Cell Signaling Technology Immunoprecipitation Testing Product Portfolio
- 8.9.5 Cell Signaling Technology Recent Developments
- 8.10 Geno Technology
- 8.10.1 Geno Technology Company Information
- 8.10.2 Geno Technology Business Overview
- 8.10.3 Geno Technology Immunoprecipitation Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Geno Technology Immunoprecipitation Testing Product Portfolio
- 8.10.5 Geno Technology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Immunoprecipitation Testing Value Chain Analysis
- 9.1.1 Immunoprecipitation Testing Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Immunoprecipitation Testing Production Mode & Process
- 9.2 Immunoprecipitation Testing Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Immunoprecipitation Testing Distributors
- 9.2.3 Immunoprecipitation Testing Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst